China Life Insurance Annual Report: Key Financial Highlights and Market Implications

Financial Summary

The 2023 annual report shows China Life Insurance posted a net profit of ¥45.6 billion, a 4.2% increase year‑over‑year, driven by higher life‑policy sales and improved investment returns. Total assets rose to ¥2.8 trillion, while the combined ratio improved to 94.5%, indicating better underwriting efficiency.

Revenue and Premium Growth

Gross written premiums reached ¥1.2 trillion, up 3.8% from the previous year. The growth was strongest in urban centers such as Beijing and Shanghai, where market penetration continues to expand. Rural premium growth lagged, reflecting slower income growth and lower insurance awareness.

Investment Portfolio Performance

Investment income contributed ¥12.3 billion, a 6.5% rise, thanks to a shift toward higher‑yield bonds and selective equity holdings. The company reduced its exposure to offshore assets, now comprising 12% of the portfolio versus 18% a year earlier, to mitigate currency risk.

Capital Adequacy and Solvency

China Life's solvency ratio stood at 219%, well above the regulatory minimum of 150%. The robust capital base supports ongoing dividend payouts and future product development. The company announced a ¥5 billion dividend, reflecting confidence in cash flow stability.

Strategic Outlook

Management emphasizes digital transformation, aiming to increase online policy issuance by 15% over the next two years. Partnerships with fintech firms are slated to enhance customer data analytics, targeting more personalized product offerings. Expansion into health‑insurance segments is also a priority, aligning with aging demographics.

Comparative Table of Key Metrics